Lauren B. Angelo

2 days ago | drugtopics.com | Ashley Gallagher |Lauren B. Angelo

This interview was recorded on June 4, 2025, at 11:00 am. Lauren Angelo, PharmD, MBA, associate dean of academic affairs at Rosalind Franklin University of Medicine and Science, highlights significant concerns about the evolving landscape of COVID-19 vaccine policy, particularly focusing on the complex challenges surrounding vaccine access, recommendations, and public perception.

3 days ago | drugtopics.com | Ashley Gallagher |Lauren B. Angelo

This interview was recorded on June 4, 2025, at 11:00 am. The 2025-2026 COVID-19 vaccine formulation is set to remain monovalent, targeting the JN.1 lineage of the SARS-CoV-2 virus, with a preference for the LP8.1 strain.

2 months ago | drugtopics.com | Ashley Gallagher |Ravi Patel |Alisha Reed |Susan Cornell |Kari Franson |Lauren B. Angelo

The conversation highlights the rapidly evolving landscape of pharmacy, with a strong emphasis on technological innovation, professional development, and advocacy.

2 months ago | drugtopics.com | Ashley Gallagher |Lauren B. Angelo

In an era of persistent medical misinformation and deep-rooted health care disparities, addressing vaccine hesitancy has become a critical challenge for health care professionals.

2 months ago | drugtopics.com | Ashley Gallagher |Lauren B. Angelo

Lauren Angelo, PharmD, associate dean for academic affairs at Rosalind Franklin University, discusses vaccine hesitancy, myths, and the critical challenges in health care communication and access. Angelo highlights persistent misconceptions about vaccine safety, including the debunked link between the MMR vaccine and autism and ongoing misinformation surrounding COVID-19 vaccines.